Skip to main content

Latest SEC Filings — Page 103

Page 103 · 30 filings scored 7+ · newest 8:21 AM ET · How scores work

Fri, Oct 1628 filings
8LEENLeopard Energy, Inc.Leopard Energy 10-K: Going-Concern Warning, $34K Annual Loss, Material WeaknessesForm 10-K · Periodic report▼ NegativePro7SFDSmithfield Foods, Inc.Smithfield Signs $600M Delayed Draw Term Loan to Redeem 4.250% Notes Due 2027Form 8-K · Current report● Neutral7PBAMPrivate Bancorp of America, Inc.PBAM Q3 EPS $1.97 as Criticized Loans Jump to 3.29% of PortfolioForm 8-K · Current report● Neutral7XOMExxonMobil Holdings CorpExxonMobil Guides 3Q26 Earnings: Margins Add $4.4B, Timing Effects Cut $2.5BForm 8-K · Current report● Neutral7IMRNImmuron LtdImmuron AGM Seeks 10% Extra Placement Capacity; Contested Board Seat on BallotForm 6-K · Current report▼ Negative8ASSTStrive, Inc.Strive Prices Upsized $630M SATS Preferred Offering at $90/ShareForm 8-K · Current report● NeutralPro7EARNEllington Credit CoEllington Credit Authorizes $20M Buyback With Shares Below Estimated NAVForm 8-K · Current report▲ Positive7EBSEmergent BioSolutions Inc.Emergent CFO Lindahl to Retire Dec 31; Treasurer Frank Vargo Named Interim CFOForm 8-K · Current report● Neutral7CYCUCycurion, Inc.Cycurion CEO Details $54.6M Contract Start, ~$30M Run Rate, and Predictive Cyber RelaunchForm 8-K · Current report● Neutral7IRWDIronwood Pharmaceuticals, Inc.Ironwood Names Tammi Gaskins CEO; McCourt Retires After 17 YearsForm 8-K · Current report● Neutral8NCINeo-Concept International Group Holdings LtdNeo-Concept Dismisses Auditor WWC, Appoints Privatco CPA Effective ImmediatelyForm 6-K · Current report▼ NegativePro7CLPSCLPS IncCLPS FY2026: Net Loss Widens to $12.9M, Gross Margin Falls to 17.8%Form 20-F · Periodic report▼ Negative9GUTSFractyl Health, Inc.Fractyl's Revita Hits Pivotal Endpoint: 80% Weight Loss Retained vs 67% Sham (p=0.0023)Form 8-K · Current report▲ PositivePro7RYMRYTHM, Inc.RYTHM Adds Señorita Brand to Green Thumb License, Lifts Annual Fee to $64.25MForm 8-K · Current report▲ Positive7TLSATiziana Life Sciences LtdTiziana Doses Last Alzheimer's Patient; Phase 2 Topline Data Due Q1 2027Form 6-K · Current report▲ Positive8VCTRVictory Capital Holdings, Inc.Victory Capital Sets Nov 17 Vote on $7.03B First Eagle Deal and 17.4% Share IssuanceDEFM14A · Proxy● NeutralPro7NINiSource Inc.NiSource Signs 20.5-Year, ~$2.2B Battery Storage Tolling Deal for 600 MW ProjectForm 8-K · Current report▲ Positive7LILi Auto Inc.Li Auto Raises RMB1.625B for Chip Unit MHX at RMB16.63B Valuation, Retains ~74-76% StakeForm 6-K · Current report● Neutral7TRVThe Travelers Companies, Inc.Travelers Q3 Net Income $1.92B, Core EPS $9.18; $1.5B Buyback, Dividend Held at $1.25Form 8-K · Current report● Neutral7NCINeo-Concept International Group Holdings LtdNCI Calls Oct 29 EGM to Vote on Share Consolidation of 2-for-1 Up to 400-for-1Form 6-K · Current report▼ Negative7CFGCitizens Financial Group, Inc.Citizens Financial Q3 EPS $1.41 (+34% YoY); Dividend Raised 13%, Buyback Capacity Up $1.3B to $1.95BForm 8-K · Current report▲ Positive7TFCTruist Financial CorporationTruist Q3 2026: Adjusted EPS $1.16, LightStream Sale to Carlyle, 4Q26 Guidance SetForm 8-K · Current report● Neutral8ACNAccenture plcAccenture 10-K: FY26 Revenue $74.2B, EPS $13.56; DOJ Probe of Federal Unit DisclosedForm 10-K · Periodic report● NeutralPro8BVCBitVentures LtdBitVentures FY2026: US$3.4M Net Income Masks Material Weaknesses and 90% Revenue CollapseForm 20-F · Periodic report▼ NegativePro8FRMIFermi Inc.Fermi Wins MUFG Covenant Waiver, Defers ~$56M of Principal for $25M in FeesForm 8-K · Current report▲ PositivePro8INSWInternational Seaways, Inc.International Seaways to Acquire Bruton Limited for ~$370M, Issuing ~3.12M SharesForm 8-K · Current report▲ PositivePro8LOOPLoop Industries, Inc.Loop 10-Q: Going Concern Warning, $836K Cash, New India JV License DealsForm 10-Q · Periodic report▼ NegativePro7EQBKEquity Bancshares, Inc.Equity Bancshares Q3 Core EPS $1.40, Record Loan Production; Lincoln Close on Track for Q4Form 425 · Proxy● Neutral
Thu, Oct 152 filings
8ENSCEnsysce Biosciences, Inc.Ensysce 8-K/A No. 2 Details Cy Biopharma Deal: Going-Concern Target, $79M IPR&D Write-Off, Nasdaq Listing RiskForm 8-K/A · Current report▼ NegativePro8ASSTStrive, Inc.Strive Upsizes SATS Preferred IPO to $630M at $90/Share, 15% DividendFWP▼ NegativePro
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.